The Ultimate Guide to Medical Devices Submission Pathways

Samd For Digital Diagnosis Comparing Us And Eu Regulation

The ever-evolving landscape of medical devices requires robust regulatory pathways to approve these innovative solutions. This fact is especially true for regulatory affairs professionals in the medical device industry. Navigating through the United States Food and Drug Administration (FDA) regulations to get clearance or approval for your device is a complex but crucial process. In this post, we’ll offer an all-encompassing rundown of submission pathways, including an explanation of why understanding these pathways is essential, a walk-through of the 510(k), De Novo, and Pre-Market Approval (PMA) pathways, and tips for submission support.

Disclaimer: Although some Class I and II devices don’t require FDA clearance and can be introduced to the market with the right development process and a robust Quality Management System (QMS), it’s crucial to remember that as device class ascends from Class I to Class III, regulatory controls intensify. Always consult the FDA guide to understand any exceptions and ensure compliance.

Understanding Medical Devices Submission Pathways (and Why They Matter)

Submission pathways are regulatory processes laid out by the FDA for medical device manufacturers to ensure safety and efficacy before these devices hit the market. Understanding these pathways is vital as it provides a smooth transition from development to market entry, enabling quicker patient access to these devices.

To successfully navigate the submission pathways, medical device manufacturers must first identify which pathway is most appropriate for their product. Then, they need to compile a detailed submission that meets the criteria for that specific pathway. The FDA provides comprehensive guidance documents, acceptance checklists, and flowcharts to aid this process. Each pathway has unique requirements dictated by factors such as the risk classification of the device and its similarity or lack thereof to existing, legally marketed devices. Here’s a quick recap of each of them:

1. The 510(k) Pathway

The 510(k) pathway is named after Section 510(k) of the Federal Food, Drug, and Cosmetic Act. It requires manufacturers to submit a pre-market notification demonstrating that the device is substantially equivalent to a legally marketed device (predicate device). The goal is to show that the new device has similar technological characteristics and is intended to be used as the predicate device.

To obtain clearance through this pathway, manufacturers must prepare a comprehensive submission including information about the new device’s intended use, design features, performance data from testing or clinical studies if necessary, labeling details, etc. The FDA reviews this submission to determine whether substantial equivalence exists between the new device and its predicate.

Who Qualifies for the 510(k) Pathway?

The 510(k) pathway is suitable for manufacturers with medical devices that are not classified as high risk and have a legally marketed predicate. The device must not only share similar technological characteristics with the predicate but also the same intended use. This pathway is most common for Class II devices, although some Class I and Class III devices may also be eligible.

2. The De Novo Pathway (Section 513(f)(2))

The De Novo pathway provides an alternative route for novel medical devices with no legally marketed predicate upon which substantial equivalence can be demonstrated. This pathway allows manufacturers to request the classification of their devices into Class I or Class II, or Class III based on their risk profile.

Manufacturers submit a De Novo request containing detailed information about their device’s intended use, technological characteristics, safety data from nonclinical testing or clinical studies if applicable, and labeling information, including indications for use and contraindications if any exist. Upon review of the submission by FDA experts in relevant fields such as engineering or medicine who evaluate the safety and effectiveness aspects of the device, the FDA determines whether to grant De Novo classification, which establishes a new regulatory classification for the device.

Who Qualifies for the De Novo Pathway?

The De Novo pathway is tailored for devices that are novel and for which there are no existing legally marketed predicates. These are typically low-to-moderate risk devices that have been initially classified as Class III (high risk) due to the lack of a predicate but do not fit the definition of Class III. Through the De Novo pathway, these devices can be reclassified into Class I or Class II after a risk-based evaluation of the device’s safety and effectiveness. It is recommended to approach the FDA during the development phase and schedule a Pre-Sub Meeting, to obtain agreement on the classification, the route to market, and the clinical plan.

3. The PMA Pathway

The Pre-Market Approval (PMA) pathway is the most stringent regulatory pathway for medical devices. It applies to high-risk devices or those with no legally marketed predicate device available for comparison.

To obtain PMA approval, manufacturers must provide comprehensive scientific evidence demonstrating safety and effectiveness through clinical trials, nonclinical testing data, manufacturing information, including quality control measures and facility inspections, and labeling details such as indications for use and warnings or contraindications if applicable. The FDA reviews this extensive submission in detail and decides based on the evaluation of scientific evidence provided by the manufacturer. A PMA application grants permission to market the device in question if approved through this pathway.

Who Qualifies for the PMA Pathway?

The PMA pathway is intended for Class III medical devices, which are usually high-risk devices or those that support or sustain human life. These devices do not have a suitable predicate to use for a 510(k) submission, and the potential risks associated with the device cannot be controlled by general or special controls. Examples may include heart valves, silicone gel-filled breast implants, and implanted cerebellar stimulators. Manufacturers seeking approval through this pathway must provide extensive clinical evidence demonstrating the device’s safety and efficacy.

What you need to remember: for 510(k) submissions, manufacturers must demonstrate that their device is substantially equivalent to a predicate device. De Novo’s requests, on the other hand, involve demonstrating the safety and efficacy of novel, low-to-moderate-risk devices. In contrast, the PMA pathway requires manufacturers to provide substantial evidence of the device’s safety and effectiveness for its intended use through scientific data.

  510(k) Pathway  De Novo Pathway  PMA Pathway 
Purpose  For devices that are substantially equivalent to a legally marketed device.  For novel, low-to-moderate risk devices that lack a predicate.  For high-risk devices that sustain or support human life, are of substantial importance in preventing impairment of human health or present a potential unreasonable risk of illness or injury. 
Qualification  Most common for Class II devices, though some Class I and Class III devices may also be eligible.  Typically for low-to-moderate risk devices initially classified as Class III due to lack of a predicate but do not fit the definition of Class III.  Class III medical devices, which are high-risk devices or those that support or sustain human life. 
Submission Requirement  Premarket Notification, substantial equivalence to a predicate device must be shown.  De Novo request, proof of safety and efficacy.  Premarket Approval Application, comprehensive scientific evidence from clinical trials demonstrating safety and efficacy. 
FDA Evaluation  FDA determines substantial equivalence between the new device and its predicate.  FDA experts review safety and efficacy aspects, determining whether to grant De Novo classification.  Extensive FDA review, evaluation of scientific evidence provided by the manufacturer. 
Post-market Surveillance  Manufacturers must track and report certain types of post-market surveillance data to the FDA.  Manufacturers may also be required to conduct post-market surveillance studies to gather additional safety and effectiveness data.  Manufacturers are generally required to conduct post-approval studies to verify the device’s safety and efficacy. 
Timeframe  Typically 90 days, but can vary depending on the completeness of the application and FDA’s query.  Approximately 120 days (about 4 months) from the receipt of a complete De Novo request.  It can take six months to a year or more depending on the complexity of the device and the completeness of the application. 
Cost  User fee applies, typically lower than PMA.  User fee applies, typically lower than PMA but higher than 510(k).  Highest user fee, given the complexity and thoroughness of the review. 


How to Navigate Submission Pathways for Medical Devices

Navigating these pathways requires careful planning, thorough documentation, and rigorous testing. Each pathway has unique requirements. For example, the 510(k) pathway requires evidence of substantial equivalence to a predicate device. The De Novo pathway requires proof of safety and effectiveness for novel devices, while the PMA pathway requires extensive scientific evidence from clinical trials.

RegAsk can provide support for:

  1. QMS Preparation, Maintenance, and Audits: A robust Quality Management System (QMS) is essential for medical device companies to ensure the consistent quality, safety, and effectiveness of their devices. RegAsk steps in as a strategic partner, offering expert guidance in the preparation and maintenance of your QMS, ensuring it meets all regulatory benchmarks. Our team understands the importance of audit readiness, assisting companies in ensuring they’re always prepared for any regulatory scrutiny.
  2. Pre-Submission: The pre-submission process involves engaging with the FDA before the actual regulatory submission is made. It provides an opportunity to obtain feedback on specific questions and elements related to your device, clinical studies, and the upcoming formal submission. This step will help you decide the most appropriate regulatory pathway for your device, whether it’s 510(k), De Novo, or PMA. RegAsk can assist you with this step, helping you clarify any uncertainties or address any potential concerns regarding the upcoming formal submission.
  3. Process Flowcharts: Process flowcharts provided by RegAsk can give you a visual representation of the entire submission process. This helps your team understand what steps need to be taken, in what order, and what potential roadblocks might occur. By providing a clear roadmap of the submission process, potential pitfalls can be anticipated and planned for, which can increase the chances of a successful first-time submission.
  4. Device Classification and Justification: Choosing the correct classification for your device can greatly impact the regulatory pathway, the depth of evidence required, and the time and cost to market. RegAsk’s expertise in device classification and the ability to provide robust justifications for these classifications can prevent unnecessary regulatory scrutiny, saving your organization time and resources.
  5. Comprehensive list of documents required for the submissions: A list of required documents, custom-tailored for each submission pathway, is invaluable in the preparation process. RegAsk helps by providing this list, saving your team the time and effort of gathering this information manually. Having all necessary documents at your disposal ensures a smoother submission process, reducing potential back-and-forths with the FDA.
  6. Acceptance Checklists: Having a clear, comprehensive checklist is key to ensuring that all necessary information and documentation are included in your submission. Missing or incomplete information can lead to delays, requests for additional information, or even refusal of your submission. RegAsk’s acceptance checklists help your team stay organized and ensure that you meet every FDA requirement, which can expedite your device’s time to market.
  7. Risk-Benefit Assessment: A thorough risk-benefit assessment is a crucial part of the submission process. RegAsk can help your team identify and assess potential risks associated with your device, as well as how those risks weigh against the device’s benefits. This critical analysis can provide assurance to the FDA of your device’s safety and efficacy, making the approval process more seamless.
  8. Submission Support: Navigating the submission process can be complex and demanding. RegAsk’s submission support can take the pressure off your internal team by managing the submission process. With deep expertise in FDA requirements and submission processes, RegAsk can guide your submission towards a successful outcome, avoiding common pitfalls and easing the burden on your internal resources.
  9. Submission: The submission phase is when the actual regulatory submission package is formally submitted to the FDA for review. This submission has to contain all the necessary data and information needed for the FDA to evaluate the safety, efficacy, and quality of the medical device. RegAsk can assist you with this step, helping you present your product’s unique characteristics and strategic goals.
  10. Post-Submission: Engaging with the FDA doesn’t end with the submission. RegAsk can facilitate post-submission communications, addressing any queries or clarifications the FDA might have, ensuring a smoother review process.


Our Tips and Tricks for a Smooth Medical Devices Submission

  • Start early: Preparing a submission can be time-consuming; start your preparations early to avoid last-minute rushes.
  • Be thorough: Provide all required information, and ensure your data is accurate and complete.
  • Seek help when needed: Organizations like RegAsk can offer invaluable assistance with various aspects of the submission process, from acceptance checklists to submission support.


Simplifying the Journey Through Medical Devices Submission Pathways

The FDA’s 510(k), De Novo, and PMA pathways offer distinct regulatory routes for medical device manufacturers based on their device’s risk profile and similarity or novelty compared to existing devices. Successfully navigating these pathways is crucial to ensuring compliance with FDA regulations and gaining market access to your medical devices. Let our team at RegAsk help simplify your regulatory journey. From deciphering the right pathway for your medical device to assisting with the final submission, we’re here to guide you every step of the way.

Ready to embark on your regulatory journey with a reliable partner at your side? Contact our team of specialists at RegAsk today for comprehensive, personalized support. Let us help you navigate these regulatory waters with ease. Your success is our mission.

Have questions on Medical Devices Submission Pathways?

Speak to our experts



Have a
regulatory affairs

Regulatory Affair Icon